Multi-criteria optimization achieves superior normal tissue sparing in intensity-modulated radiation therapy for oropharyngeal cancer patients.
暂无分享,去创建一个
Yan Li | Jianghong Xiao | Nianyong Chen | Tangel Chang | Xuetao Wang | Jianghong Xiao | Huashan Shi | Tangel Chang | Yong Luo | Xuetao Wang | Yang He | Huashan Shi | N. Chen | Yan Li | Yang He | Yong Luo | Yang He
[1] J. Deasy,et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. , 2001, International journal of radiation oncology, biology, physics.
[2] Sandra Nuyts,et al. Radiation‐induced xerostomia in patients with head and neck cancer , 2006, Cancer.
[3] V. Wu,et al. A comparison between anisotropic analytical and multigrid superposition dose calculation algorithms in radiotherapy treatment planning. , 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[4] David Craft,et al. Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] Fernando Alonso,et al. A new concept for interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] Donna C. Tippett,et al. Swallowing outcomes in patients with oropharyngeal cancer undergoing organ‐ preservation treatment , 2014, Head & neck.
[7] Mika Kapanen,et al. Quantification of dose differences between two versions of Acuros XB algorithm compared to Monte Carlo simulations — the effect on clinical patient treatment planning , 2015, Journal of applied clinical medical physics.
[8] L. van der Molen,et al. Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] Jayashree Kalpathy-Cramer,et al. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] Marta Paiusco,et al. IMRT treatment planning:- a comparative inter-system and inter-centre planning exercise of the ESTRO QUASIMODO group. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] F. Feng,et al. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.
[12] K. Griffith,et al. Patient-reported voice and speech outcomes after whole-neck intensity modulated radiation therapy and chemotherapy for oropharyngeal cancer: prospective longitudinal study. , 2014, International journal of radiation oncology, biology, physics.
[13] J. Deasy,et al. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. , 2017, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[14] Joseph O Deasy,et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[15] David Craft,et al. Maximizing dosimetric benefits of IMRT in the treatment of localized prostate cancer through multicriteria optimization planning. , 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[16] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[17] Jiazhou Wang,et al. Investigation of plan quality between RapidArc and IMRT for gastric cancer based on a novel beam angle and multicriteria optimization technique. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] P. Levendag,et al. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer , 2013, The Laryngoscope.
[19] J. Sciubba,et al. Oral complications of radiotherapy. , 2006, The Lancet. Oncology.
[20] Kristoffer Petersson,et al. Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] A. Garden,et al. A multi‐institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity‐modulated radiotherapy , 2015, Cancer.
[22] Avraham Eisbruch,et al. Intensity-modulated radiation therapy for head and neck carcinoma. , 2007, The oncologist.
[23] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[24] B. Murphy,et al. Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement. , 2016, Critical reviews in oncology/hematology.
[25] Ping Xia,et al. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer. , 2008, International journal of radiation oncology, biology, physics.
[26] J. Giralt,et al. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations , 2010, Expert review of anticancer therapy.
[27] P. Levendag,et al. Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long‐term survivors , 2002, Head & neck.
[28] Christian Richter,et al. Deliverable navigation for multicriteria step and shoot IMRT treatment planning , 2012, Physics in medicine and biology.
[29] S. Loewen,et al. Prospective swallowing outcomes after IMRT for oropharyngeal cancer: Dosimetric correlations in a population-based cohort. , 2016, Oral oncology.
[30] David Craft,et al. An approach for practical multiobjective IMRT treatment planning. , 2007, International journal of radiation oncology, biology, physics.
[31] Philippe Després,et al. Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma. , 2012, International journal of radiation oncology, biology, physics.
[32] Heikki Joensuu,et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[33] A. Garden,et al. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes , 2014, Radiation oncology.
[34] Ryan S. Lee,et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience. , 2017, Oral oncology.
[35] G. Calais,et al. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] R. Fisher,et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Rasmus Bokrantz,et al. Advantages and limitations of navigation-based multicriteria optimization (MCO) for localized prostate cancer IMRT planning. , 2014, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[38] S. Franceschi,et al. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study. , 2017, Oral oncology.
[39] Suzanne L Wolden,et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. , 2012, International journal of radiation oncology, biology, physics.
[40] J. Shah,et al. Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. , 2012, International journal of radiation oncology, biology, physics.
[41] Fredrik Carlsson,et al. Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head. , 2008, International journal of radiation oncology, biology, physics.